logo
Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

National Post6 hours ago

Article content
GENEVA — Six leading international organizations representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry have today adopted the first joint ethical principle in the healthcare industry on the responsible use of health data and technology, including artificial intelligence.
Article content
The new principle joins the International Consensus Framework for Ethical Collaboration in Health, guiding ethical collaboration across bodies representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry.
Article content
The new principle joins the International Consensus Framework for Ethical Collaboration (ICF), a longstanding principles-based voluntary agreement that guides ethical collaboration across these major healthcare bodies, working together to deliver high quality care for patients.
Article content
The ICF was established in 2014 as a global platform to ensure that relationships across the health ecosystem are grounded in ethical, transparent, and responsible decision-making. It unites six leading health bodies representing patient organizations, healthcare professionals, and the pharmaceutical industry.
Article content
The founding principles of the ICF focus on prioritizing patients; supporting ethical research and innovation; ensuring independence and ethical conduct; and promoting transparency and accountability.
Article content
The new fifth principle focuses on autonomy, data stewardship, and shared accountability in the use of health data. This reflects the growing importance of digital health and AI, and the need for ethical considerations to evolve alongside scientific innovation.
Article content
'No single hospital or stakeholder can navigate today's rapid advances in health data and technology alone,' said Ronald Lavater, CEO of the International Hospital Federation. 'The ICF enables collective action, empowering global health leaders to build trusted partnerships that unlock the full potential of ethical, person-centered innovation.'
Article content
'Data and technology may evolve care delivery, but ethics guides our why, how and for whom,' said Howard Catton, CEO of the International Council of Nurses. 'This principle affirms the enduring importance of trust, compassion, and dignity — values nurses uphold every day across health systems worldwide.'
Article content
Patient voices are central to the adoption of this principle. 'This new principle is a major step forward in safeguarding the rights of patients and people with lived experience in the digital age,' said Dani Mothci, CEO of the International Alliance of Patients' Organizations. 'As a founding member of the ICF, IAPO welcomes the clear ethical commitment around autonomy, data stewardship, and accountability highlighting focus on putting patients first. To make this a reality, we encourage patient organizations to actively engage with this principle and ensure its implementation reflects real-world patient experiences.'
Article content
'Ethics is the cornerstone of effective global health policy. It ensures that decisions are guided by fairness, respect, and accountability. The World Medical Association believes that ethical collaboration is essential to building resilient health systems and delivering better care to all, especially the most vulnerable,' said Dr. Ashok Philip, President of the World Medical Association.
Article content
Paul Sinclair, President of the International Pharmaceutical Federation, called on pharmacy professionals to embrace the new principle: 'FIP supports ethical and responsible decision making, which involves pharmacy practitioners in relation to patients, healthcare professionals, and the pharmaceutical sector to ensure high-quality care. I invite all our members to adopt and adapt this framework at the country and regional levels of practice.'
Article content
David Reddy, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, echoed the call for collective responsibility: 'For the past decade, the ICF has fostered stronger alliances and shared values between key partners involved in healthcare delivery, through sustained engagement on emerging ethical challenges. Today, by integrating a new principle on digital health and AI, we're echoing a growing consensus: as innovation accelerates, ethical collaboration must evolve in tandem. Our focus is on delivering for patients — first and always.'
Article content
Established in 2014, the
Article content
International Consensus Framework for Ethical Collaboration
Article content
is the only global platform of its kind that brings together patients' organizations, healthcare professionals, and the pharmaceutical industry in support of high-quality, patient-centered care. The Framework is jointly supported by six leading bodies – the
Article content
,
Article content
,
Article content
IFPMA
Article content
,
Article content
FIP
Article content
,
Article content
WMA
Article content
, and
Article content
IHF
Article content
– all united by a shared commitment to ensuring that relationships across the health ecosystem are grounded in ethical, transparent, and responsible decision-making. The Consensus Framework is a living document and is open to other stakeholders in life sciences and healthcare delivery, who are encouraged to endorse and contribute to its evolution. It is guided by four founding principles: put patients first; support ethical research and innovation; ensure independence and ethical conduct; promote transparency and accountability. In 2025, the Framework was expanded to include a fifth principle: uphold responsible use of health data and technology. This reflects the growing importance of digital health and AI, and the need for ethics to evolve alongside innovation.
Article content
Article content
Article content
Article content
Contacts
Article content
Media contacts
Article content
Article content

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why bad dreams could be aging and prematurely killing you
Why bad dreams could be aging and prematurely killing you

National Post

time42 minutes ago

  • National Post

Why bad dreams could be aging and prematurely killing you

Nightmares can literally scare the life out of people, new research suggests. Article content Frequent unpleasant dreams and nightmares are being linked with accelerated biological aging and an untimely death. Article content According to a British team, people who experience weekly distressing dreams are three times more likely to die before they reach age 70 than people who rarely or never report experiencing nightmares. Article content Article content Article content Telomeres get shorter every time a cell divides, and shorter telomeres are considered a sign of accelerated aging of the body's cells. Cortisol is present at high levels during nightmares. Article content 'For those who frequently experience nightmares, this cumulative stress may significantly impact the aging process,' the study's lead author, Dr. Abidemi Otaiku, of the UK Dementia Research Institute and Imperial College London, said in a statement released this week. Article content What's more, nightmares mess with how well and how long people sleep, 'impairing the body's essential overnight cellular restoration and repair,' Otaiku said. 'The combined effects of chronic stress and disrupted sleep likely contribute to the accelerated aging of our cells and bodies.' Article content Article content Nightmares are common, Otaiku reported in earlier work linking nightmares with an i ncreased risk of dementia and cognitive decline in middle-aged adults. Article content Article content About five percent of adults experience nightmares weekly, and up to 40 percent monthly, percentages that are likely even higher if bad dreams are thrown in, he said. Considering how common a phenomenon nightmares are, 'it is surprising that their clinical significance remains largely unknown,' he wrote. Article content In the latest study, presented this week at the European Academy of Neurology Congress in Helsinki, Otaiku and colleagues analyzed pooled data from 2,429 children aged eight to 10, and 183,012 adults aged 26 to 86 from six cohort studies following large groups of people over time. Article content Adults reported how often they had nightmares at the start of the study, and were followed for up to 19 years. For kids, nightmare frequency was reported by parents. Article content According to a release, adults reporting weekly nightmares were three times as likely to die prematurely than people who rarely or never experienced distressing dreams. 'Children and adults with more frequent nightmares also exhibited faster biological aging, which accounted for approximately 40 percent of the heightened mortality risk' among adults, according to the release.

Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare
Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

National Post

time6 hours ago

  • National Post

Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

Article content GENEVA — Six leading international organizations representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry have today adopted the first joint ethical principle in the healthcare industry on the responsible use of health data and technology, including artificial intelligence. Article content The new principle joins the International Consensus Framework for Ethical Collaboration in Health, guiding ethical collaboration across bodies representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry. Article content The new principle joins the International Consensus Framework for Ethical Collaboration (ICF), a longstanding principles-based voluntary agreement that guides ethical collaboration across these major healthcare bodies, working together to deliver high quality care for patients. Article content The ICF was established in 2014 as a global platform to ensure that relationships across the health ecosystem are grounded in ethical, transparent, and responsible decision-making. It unites six leading health bodies representing patient organizations, healthcare professionals, and the pharmaceutical industry. Article content The founding principles of the ICF focus on prioritizing patients; supporting ethical research and innovation; ensuring independence and ethical conduct; and promoting transparency and accountability. Article content The new fifth principle focuses on autonomy, data stewardship, and shared accountability in the use of health data. This reflects the growing importance of digital health and AI, and the need for ethical considerations to evolve alongside scientific innovation. Article content 'No single hospital or stakeholder can navigate today's rapid advances in health data and technology alone,' said Ronald Lavater, CEO of the International Hospital Federation. 'The ICF enables collective action, empowering global health leaders to build trusted partnerships that unlock the full potential of ethical, person-centered innovation.' Article content 'Data and technology may evolve care delivery, but ethics guides our why, how and for whom,' said Howard Catton, CEO of the International Council of Nurses. 'This principle affirms the enduring importance of trust, compassion, and dignity — values nurses uphold every day across health systems worldwide.' Article content Patient voices are central to the adoption of this principle. 'This new principle is a major step forward in safeguarding the rights of patients and people with lived experience in the digital age,' said Dani Mothci, CEO of the International Alliance of Patients' Organizations. 'As a founding member of the ICF, IAPO welcomes the clear ethical commitment around autonomy, data stewardship, and accountability highlighting focus on putting patients first. To make this a reality, we encourage patient organizations to actively engage with this principle and ensure its implementation reflects real-world patient experiences.' Article content 'Ethics is the cornerstone of effective global health policy. It ensures that decisions are guided by fairness, respect, and accountability. The World Medical Association believes that ethical collaboration is essential to building resilient health systems and delivering better care to all, especially the most vulnerable,' said Dr. Ashok Philip, President of the World Medical Association. Article content Paul Sinclair, President of the International Pharmaceutical Federation, called on pharmacy professionals to embrace the new principle: 'FIP supports ethical and responsible decision making, which involves pharmacy practitioners in relation to patients, healthcare professionals, and the pharmaceutical sector to ensure high-quality care. I invite all our members to adopt and adapt this framework at the country and regional levels of practice.' Article content David Reddy, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, echoed the call for collective responsibility: 'For the past decade, the ICF has fostered stronger alliances and shared values between key partners involved in healthcare delivery, through sustained engagement on emerging ethical challenges. Today, by integrating a new principle on digital health and AI, we're echoing a growing consensus: as innovation accelerates, ethical collaboration must evolve in tandem. Our focus is on delivering for patients — first and always.' Article content Established in 2014, the Article content International Consensus Framework for Ethical Collaboration Article content is the only global platform of its kind that brings together patients' organizations, healthcare professionals, and the pharmaceutical industry in support of high-quality, patient-centered care. The Framework is jointly supported by six leading bodies – the Article content , Article content , Article content IFPMA Article content , Article content FIP Article content , Article content WMA Article content , and Article content IHF Article content – all united by a shared commitment to ensuring that relationships across the health ecosystem are grounded in ethical, transparent, and responsible decision-making. The Consensus Framework is a living document and is open to other stakeholders in life sciences and healthcare delivery, who are encouraged to endorse and contribute to its evolution. It is guided by four founding principles: put patients first; support ethical research and innovation; ensure independence and ethical conduct; promote transparency and accountability. In 2025, the Framework was expanded to include a fifth principle: uphold responsible use of health data and technology. This reflects the growing importance of digital health and AI, and the need for ethics to evolve alongside innovation. Article content Article content Article content Article content Contacts Article content Media contacts Article content Article content

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

Globe and Mail

time7 hours ago

  • Globe and Mail

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ| TSX: ACB EDMONTON, AB, June 26, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store